Albemarle offers high-risk, high-upside exposure to lithium recovery, supported by tier-one low-cost assets, improving cash flow, and a probability-weighted five-year value of $278.25.
Overview
Albemarle is a global specialty-chemicals producer with Energy Storage, Specialties, and Ketjen operations, generating approximately 53%, 26%, and 21% of FY2025 sales respectively. Its core investment case rests on tier-one, low-cost lithium resources at Salar de Atacama and Greenbushes, long customer qualification cycles, and secular demand from EVs and utility-scale storage. **Q2 2026 demonstrated strong operating leverage:** revenue rose 31.1% year over year to $1.74 billion, adjusted EPS was $3.75 versus $(0.16), adjusted EBITDA increased 154.6% to $858 million, operating cash flow reached $710 million, and FCF was $638 million. Realized lithium pricing increased to $19.53/kg LCE from $12.17/kg. Management affirmed FY2026 sales guidance of $5.7 billion–$6.0 billion, raised Specialties guidance to $1.4 billion–$1.6 billion, and cut capex to approximately $500 million. **The valuation is highly asymmetric but cyclical:** the five-year scenarios range from $63.00 to $550.00 per share, with a $278.25 probability-weighted target versus a $123.50 baseline. Near-term catalysts include lithium-price stabilization, continued cost savings, debt reduction, storage growth, and the February 2027 CEO transition, while oversupply remains the central risk.